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Abstract
Objective-To determine whether limited
joint mobility (LJM) is associated with
microalbuminuria in type I diabetes
mellitus.
Methods-Joint mobility was measured in
a control group of 63 healthy subjects and
in 63 type I diabetic patients, older than 18
years (mean 31-7 years, range 18-57),
recruited from the outpatient clinic of the
Endocrine Unit. Patients with established
diabetic nephropathy (proteinuria or
increased creatinine) were excluded. Joint
mobility was assessed qualitatively with
the prayer manoeuvre and quantitatively
by measuring the angles of maximal
flexion and extension ofthe fifth and third
metacarpophalangeal (MCP) joints and
wrist. Diabetic retinopathy was assessed
by direct ophthalmoscopy. Urinary albu-
min excretion (UAE) was determined in at
least two 24 hour urine samples.
Results-Joint mobility was limited in
diabetic patients compared with control
subjects. Diabetic patients with LJM had
longer duration of diabetes (12-1 (SD 6.4)
years compared with 6-9 (5.7) years;
p < 0001). Joint mobility was limited in
patients with retinopathy: prayer man-
oeuvre was positive in 96-4% of patients
with retinopathy, but in only 4000% of
patients with no retinopathy (p < 0001);
mobility of MCP joints and wrist was
limited in diabetic patients with retino-
pathy even when the longer duration of
their diabetes was taken into consider-
ation. Microalbuminuria, present in 11
patients (17/5%), was associated with
LJM: prayer manoeuvre was positive in
90.9% of patients with microalbuminuria,
but in only 57.4% of patients with normal
UAE (p < 0.05). Maximal flexion of MCP
joints was reduced in patients with micro-
albuminuria. Microalbuminuria, but not
LJM, was associated with risk factors of
cardiovascular disease.
Conclusion-LJM is associated with
microalbuminuria and retinopathy in type
I diabetes. The association is independent
ofage and duration ofdiabetes.
(Ann Rheum Dis 1995; 54: 582-586)
Hard abnormalities, such as stiffpainful hands,
Dupuytren's contracture, skin tightness,
pseudoscleroderma, reflex sympathetic dys-
trophy, carpal tunnel syndrome, or limited
joint mobility, are frequently found in diabetic
patients. The most common hand abnormality
in diabetes is non-painful contracture of fingerjoints', referred to as limited joint mobility(LJM).2 LJM was initially described in type I
patients with long standing diabetes,3 but it is
found in both type I and type II diabetes
mellitus,4-9 and can be detected very early in
the evolution of the disease.2
The association between LJM and micro-
angiopathic complications of diabetes, particu-
larly diabetic retinopathy, has been reported
repeatedly.' 2 9`12 Although age and diabetes
duration have been found to influence the
development of LJM, their role in the asso-
ciation between LJM and retinopathy has been
controversial.'3 14 In contrast, the association
of LJM with diabetic nephropathy, a leading
cause of death in type I diabetes mellitus'5 has
been reported infrequently. A relationship was
found between already established diabetic
nephropathy and LJM in a paediatric popu-
lation,'6 and recently a decreased mobility of
MCP joints was reported in a group of elderly
diabetic patients with renal functional impair-
ment."' The early stages of diabetic nephro-
pathy can be identified by the presence of
microalbuminuria,'8 '9 but it cannot be
predicted which individuals will develop
microalbuminuria. In this study, we have
investigated whether LJM is associated with
microalbuminuria in type I diabetes. As
detection of LJM may precede that of micro-
angiopathy,2 6 the possible help of LJM in
identifying the subjects at risk for diabetic
nephropathy is discussed.
Subjects and methods
SUBJECTS
Sixty three diabetic patients conforming to the
National Diabetes Data Group criteria for type
I diabetes mellitus20 were included in the study.
Table 1 summarises their clinical character-
istics. Patients were recruited from the out-
patient clinic which they visited every two to
four months. Patients with overt diabetic
nephropathy (proteinuria greater than 500 mg/
day or increased serum creatinine), severe
neuropathy, or vasculopathy were excluded.
Subjects with a past history of joint disease
were also excluded. We have previously
reported a negative correlation between age
and joint mobility in diabetic patients21: joint
mobility was significantly greater in diabetic
subjects younger than 18. To minimise the
influence of age in the current study, therefore,
subjects younger than 18 years were excluded.
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Table 1 Clinical characteristics of diabetic patients
Age (yr) 31*7 (10-5) [18-57]
Sex (men/women) 33/30
Age at diabetes diagnosis (yr) 21-7 (9-7) [5-52]
Duration of diabetes (yr) 10-2 (6-6)
BMI (kg/rm2) 23-2 (2 5)
Blood pressure (mm Hg)
Systolic 119 (21)
Diastolic 74 (7)
Glucose (mmol/l) 11.4 (4-2)
HbA,(%) 11-1(1-6)
Insulin dose (U/kg) 0-70 (0-20)
Cholesterol (mmol/1) 5-02 (1-5)
Triglycerides (mmolA1) 0-99 (0 7)
Retinopathy (+) 28 [4440/%]
Microalbuminuria (+) 11 [1750/o]
Values are mean (SD) [range for quantitative variables or
percentage for qualitative variables]. BMI = Body mass index;
HbAl = glycated haemoglobin.
Joint mobility was also studied in a control
group of 63 healthy subjects with ages (30 5
(9-7) years) and sex distribution (32 men, 31
women) similar to those of the diabetic
patients; these subjects were not genetically
related to the diabetic patients.
STUJDY DESIGN
To assess the degree of chronic metabolic
control we calculated the mean values of
fasting blood glucose, glycated haemoglobin
(HbAl), and insulin requirement of the
preceding two years (six to eight deter-
minations). Body mass index, systolic and
diastolic blood pressures, fasting blood
glucose, HbA1, plasma cholesterol, triglycer-
ides, and creatinine were also determined
when joint mobility was measured. Stable
HbAl was determined by ion exchange chro-
matography; reference values were 6-2-9-0%.
Diabetic retinopathy was assessed by direct
ophthalmoscopy through dilated pupils and
was classified as absent, background retino-
pathy, or proliferative retinopathy. Retino-
pathy was defined as proliferative when retinal
vessel neovascularisation was present. Urinary
albumin excretion (UAE) was determined by
radioimmunoassay in at least two 24 hour
sterile urine samples. Microalbuminuria was
defined as UAE greater than 20 pug/min in two
consecutive samples, or in two of three
consecutive samples.22
Joint mobility was determined qualitatively
with the prayer manoeuvre2 and quantitatively
by measuring the maximal flexion and
extension of the fifth and third metacarpo-
phalangeal (MCP) joints and wrist. The prayer
manoeuvre was defined as positive when
subjects were unable to oppose palmar surfaces
at any interphalangeal or MCP joint. To
measure the angles of active maximal flexion
and extension of the fifth MCP joint, the fourth
finger was fixed on a flat surface and the subject
was asked to actively perform the flexion or
extension of the fifth finger at the level of the
MCP joint. The angles of maximal flexion and
extension were measured with a goniometer
and expressed in degrees using the zero
method. To measure the mobility of the third
MCP joint, the second finger was fixed. Arm
and forearm were fixed in complete extension
to measure the angles of active maximal flexion
and extension of the wrist. In all patients both
hands were evaluated; the mean value between
left and right measurements was used for
statistical calculations. In all joints, the corre-
lation coefficient between mean joint mobility
and right or left joint mobility was greater than
0-88 (p < 0001). All measurements were
performed by the same observer (AR) who was
unaware of the metabolic control or diabetic
complications of the patients. The mean
coefficient of variation of joint mobility
measurements repeated on six different days in
six normal subjects was less than 4% on all
joints.
The presence of shoulder capsulitis, defined
as pain in the shoulder for more than one
month with limited active and passive shoulder
joint movements in at least three planes, was
assessed. Patients were asked about past
history of painful shoulder. Dupuytren's
contracture, defined as palpable or visible
thickening of the palmar fascia overlying the
flexor tendons, was also determined.
STATISTICAL ANALYSIS
Results are expressed as mean (SD). Statistical
analysis was performed with the SPSS package.
The chi square test and Student's unpaired t
test (two tailed) were used for comparisons
between groups. A covariate analysis was used
to correct for the influence of variables found
to be associated with joint mobility. p < 0-05%
was considered significant.
Results
Table 2 summarises joint mobility in the
diabetic and control groups. Diabetic patients
showed decreased joint mobility: prayer
manoeuvre was positive in 65 1% of diabetic
patients compared with 17.5% of control
subjects, and mobility of fifth and third MCP
joints was significantly reduced in diabetic
patients. Wrist mobility was similar in diabetic
and control subjects. Maximal flexion and
extension angles were significantly reduced in
all joints examined in diabetic patients with a
positive prayer manoeuvre (data not shown).
Dupuytren's contracture was present in one
subject in each group, and capsulitis was found
in two diabetic patients. A past history of
painful non-traumatic shoulder was reported
by two diabetic patients.
Age did not correlate with joint mobility in
diabetic or control subjects and patients with
positive and negative prayer manoeuvre had
Table 2 J7oint mobility in control and diabetic groups
Diabetic patients Control group
Prayer sign(+) 41 (65-1%) 11 (17-5%)***
5th Metacarpophalangeal (deg)
Flexion 81 8 (7-2) 85-6 (4-4)***
Extension 8-73 (8 4) 16 2 (7-3)***
3rd Metacarpophalangeal (deg)
Flexion 86-1 (4 2) 88-0 (3 9)*
Extension 5-56 (6 0) 14-3 (6 8)***
Wrist (deg)
Flexion 75-0 (7 2) 73-8 (6 7)
Extension 63-8 (9 2) 65-2 (5-3)
Values are mean (percent or SD). *p < 005, ***p < 0001,
compared with diabetic patients.
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similar ages (32-8 (11{0) v 29-6 (9-3) years).
Diabetic patients with a positive prayer sign
had a longer duration of diabetes than patients
with negative prayer sign (12@1 (6 4) v 6-9 (5 7)
years; p < 0 01). Chronic metabolic control,
insulin requirement, systolic and diastolic
blood pressures, cholesterol, and triglycerides
did not correlate with joint mobility.
Diabetic retinopathy was present in 44 4%
of patients; it was proliferative in four subjects.
Patients with retinopathy were older and had
a longer duration of diabetes than patients with
no retinopathy (table 3). Joint mobility was
impaired in patients with retinopathy: prayer
manoeuvre was positive in 96-4% of diabetic
patients with retinopathy, compared with
400% of patients with no retinopathy, and
joint mobility in MCP and wrist joints was
significantly decreased. Since patients with
diabetic retinopathy were older and had a
longer duration of diabetes, the relationship
between retinopathy and joint mobility was
analysed again using age and duration of
diabetes as covariates. The new analysis
showed that the limitation in joint mobility in
diabetic patients with retinopathy was inde-
pendent of their older age or longer duration
of diabetes.
Eleven patients (17.5%) had micro-
albuminuria. The mean UAE in these patients
was 67 ,ig/min (range 24-285 ,ug/min).
Table 4 summarises the clinical characteristics
and joint mobility of diabetic patients with
normal and increased UAE. Age and diabetes
duration were similar in both groups. Patients
with microalbuminuria had greater insulin
requirements, despite a tendency towards
worse metabolic control. Blood pressure was in
the normal range and differences in blood
pressure between patients with normal and
increased UAE did not reach statistical signifi-
cance. Total cholesterol was greater in patients
with microalbuminuria. Microalbuminuria was
associated with retinopathy: diabetic retino-
pathy was found in 72-7% of patients with
increased UAE, but in only 38-5% of patients
Table 3 Diabetic retinopathy andjoint mobility
No retinopathy Retinopathy
(n=35) (n=28)
Age (yr) 27-8 (8-4)
Sex (men/women) 18/17
Age at diabetes diagnosis (yr) 21-0 (9 6)
Duration of diabetes (yr) 7-3 (4 8)
BMI (kg/im2) 22-9 (2-5)
Blood pressure (mm Hg)
Systolic 113 (24)
Diastolic 70 (15)
Glucose (mmolI) 11-3 (4 2)
HbA, (%) 11-3 (1-8)
Insulin dose (U/kg) 0-68 (0 20)
Cholesterol (mmol/l) 4-51 (1-3)
Triglycerides (mmol/l) 0-86 (0 54)
Microalbuminuria (+) 3 (8-6%)
Prayer sign (+) 14 (40 0%)
5th Metacarpophalangeal (deg)
Flexion 82-8 (8-3)
Extension 11.0 (8-9)
3rd Metacarpophalangeal (deg)
Flexion 87-4 (4-4)
Extension 7-29 (6-6)
Wrist (deg)
Flexion 77-2 (6 7)
Extension 67-2 (8 7)
359 (110)**
15/13
21-9 (9-4)
14-2 (6.5)***
23-4 (2 5)
126 (6)*
75 (8)
11-7 (4 2)
114 (1 3)
0 73 (0 20)
5-23 (1-8)
1-01 (0-71)
8 (28-6%)*
27 (96-4%)***
80-7 (5-7)
6-19 (7.2)*
84-7 (3.5)*
3-58 (4-8)*
72-4 (7-1)*
59.5 (8 0)*
Table 4 Urinary albumin excretion andjoint mobility
No microalbuminuna Microalbuminuria
(n = 52) (n = 11)
Age (yr) 31-6 (10-3)
Sex (men/women) 25/27
Age at diabetes (yr) 21 7 (9-7)
Duration of diabetes (yr) 9-7 (6 9)
BMI (kg/iM2) 23-0 (2-4)
Blood pressure (mm Hg)
Systolic 117 (22)
Diastolic 72 (13)
Glucose (mmol/l) 11 0 (4-1)
HbA (%) 11-1 (1-7)
Insulin dose (U/kg) 0-67 (0-2)
Cholesterol (mmol/V) 4-62 (1-3)
Triglycerides (mmolll) 0-91 (0 6)
Retinopathy (+) 20 (38 5%)
Prayer sign (+) 31 (59-6%)
5th Metacarpophalangeal (deg)
Flexion 82-7 (6 2)
Extension 9 40 (8 8)
3rd Metacarpophalangeal (deg)
Flexion 86-6 (3 6)
Extension 5-84 (6-4)
Wrist (deg)
Flexion 75-7 (7 0)
Extension 65-3 (8 8)
32-0 (11-7)
8/3
20-8 (10 4)
12-6 (4 8)
24-0 (2 7)
129 (13)
76 (9)
13-4 (4 0)
12-1 (1-1)
0-83 (0-2)*
5-85 (2.3)*
1-15 (0 9)
8 (72 2%)*
10 (90-9%)*
77-6 (9.9)*
5-54 (6-1)
83 7 (5.8)*
4-22(4-1)
71-9 (7 6)
56-7 (7.6)**
Values are mean (percent or SD). *p < 0 05, **p < 0 01 compared
with diabetic patients with normal UAE.
with normal UAE (p < 0-05). LJM was more
prevalent in patients with microalbuminuria: a
positive prayer manoeuvre was found in 90 9%
of microalbuminuric patients, but in only
57-4% of diabetic patients with normal UAE
(p < 005). The association between micro-
albuminuria and positive prayer sign was
highly significant when the duration of diabetes
was used as covariate (p < 0-01). However,
only 21 patients (404%) with normal UAE
had normal joint mobility, therefore LJM was
sensitive in identifying patients with micro-
albuminuria, but had a low specificity. MCP
joint and wrist mobility was significantly
decreased in patients with microalbuminuria
compared with diabetic patients with normal
albumin excretion (table 4).
Discussion
The increased prevalence of LJM in diabetes
has been clearly established in the past'-"1 and
our results confirm this association. LJM has
usually been measured with the prayer
manoeuvre and passive extension of the
patient's fingers, which are useful in assessing
the presence or absence of LJM, but allow a
limited evaluation of the severity of impaired
mobility. In contrast, we have determined joint
mobility both qualitatively with the prayer
manoeuvre and quantitatively by measuring
the angles of maximal extension and flexion of
MCP joints and wrist. Our results show that
LJM is associated with microalbuminuria in
type I diabetes. Patients with microalbu-
minuria had a greater prevalence of LJM and
a more severe limitation of joint mobility than
diabetic patients with normal UAE. Further-
more, LJM was associated with diabetic retino-
pathy, an association that was independent of
age or diabetes duration.
A relationship between LJM and micro-
vascular disease in the form of retinopathy has
been described in type I and type II
diabetes.' 2 9-12 The prevalence of diabetic
retinopathy23 and LJM' 2 4 9 11 increases with
duration of diabetes. However, diabetes
Values are mean (percent or SD). *p <005, **p < 001,
***p<0-001 compared with diabetic patients with no
retinopathy.
584
 group.bmj.com on May 26, 2011 - Published by ard.bmj.comDownloaded from 
Microalbuminuria and limitedjoint mobility
duration has not usually been considered when
the association between LJM and retinopathy
has been reported. In our diabetic population
we found, as expected, that joint mobility was
more severely impaired in patients with retino-
pathy and that these patients were older and
had a longer duration of diabetes than patients
with no retinopathy. When we included age
and duration of diabetes in the study of LJM
in patients with retinopathy, we found that
LJM and retinopathy are associated in type I
diabetes, irrespective of age or diabetes
duration.
The association between LJM and micro-
albuminuria had not been reported previously.
Recently Aoki et al,17 using a quantitative
method to measure joint mobility, reported the
association between mobility of MCP joints
and diabetic nephropathy in diabetic and non-
diabetic populations. They studied a group of
elderly diabetic patients, most of them non-
insulin dependent, with a wide range of
functional renal impairment including end
stage renal disease. In contrast, we analysed a
more homogeneous group: all patients had
type I diabetes mellitus and only subjects with
normal UAE or microalbuminuria were
included. Our study group was representative
of an adult population of type I diabetic
patients with medium term duration of
diabetes and moderate diabetic complications
and the prevalence of microalbuminuria in our
diabetic patients was 17-5%, well within the
range described in other diabetic populations.24
We found that LJM was more prevalent and
that the impairment of joint mobility was more
severe in patients with microalbuminuria than
in patients with normal UAE. Microalbu-
minuria is the earliest manifestation of diabetic
nephropathy and patients with microalbu-
minuria are at very high risk of progressing to
established diabetic nephropathy,25 which is a
leading cause of death and cardiovascular
disease.'5 24 However, although poor metabolic
control is a risk factor for developing diabetic
nephropathy,26 27 we cannot predict which
individuals will develop the disease.28 Since
detection of LJM may precede that of micro-
angiopathy,2 6 LJM might be a potential
marker of the risk of developing microalbu-
minuria, but our cross sectional study was not
designed to address this question. A follow up
study of the patients with LJM but normal
UAE is in progress. However, the low
specificity of LJM in our patients suggests that
its role as a marker of individuals at risk of
developing diabetic nephropathy may be
limited.
Type I diabetic patients with microalbu-
minuria show cardiovascular risk factors such
as increased blood pressure,29 30 lipid abnor-
malities,31 and insulin resistance.32 Accor-
dingly, our patients with microalbuminuria
had a high requirement for insulin despite
relatively worse metabolic control, suggesting
insulin resistance and greater cholesterol
concentrations. In contrast, we did not find
any association between LJM and blood
pressure, plasma lipids, insulin requirement, or
metabolic control; therefore, LJM is not
associated with risk factors for cardiovascular
events.
It has been suggested that the association of
LJM with long term complications of diabetes
might simply reflect longer duration of
diabetes.'3 In agreement with previous reports,
we found that patients with LJM had a longer
duration of diabetes. However, after correcting
for diabetes duration, the association between
LJM and diabetic retinopathy persisted. In
addition, patients with microalbuminuria had
LJM despite a diabetes duration similar to that
of non-microalbuminuric patients. Therefore,
our results show that the association of micro-
angiopathic complications of diabetes mellitus
and LJM in type I diabetes is independent of
the duration of diabetes.
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